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Background: In animal studies, perfluorinated alkyl substances affect growth and neuro-behavioural outcomes.
Human epidemiological studies are sparse. The aim was to investigate the association between pregnancy serum
concentrations of perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) and offspring behaviour and
motor development at 5–9 years of age.
Methods: Maternal sera from the INUENDO cohort (2002–2004) comprising 1,106 mother-child pairs from
Greenland, Kharkiv (Ukraine) and Warsaw (Poland) were analysed for PFOS and PFOA, using liquid-chromatography-
tandem-mass-spectrometry. Exposures were grouped into country specific as well as pooled tertiles as well as
being used as continuous variables for statistical analyses. Child motor development and behaviour at follow-up
(2010–2012) were measured by the Developmental Coordination Disorder Questionnaire 2007 (DCDQ) and Strength
and Difficulties Questionnaire (SDQ), respectively. Exposure-outcome associations were analysed by multiple logistic
and linear regression analyses.
Results: In the pooled analysis, odds ratio (OR) (95% confidence interval (CI)) for hyperactivity was 3.1 (1.3, 7.2)
comparing children prenatally exposed to the highest PFOA tertile with those exposed to the lowest PFOA
tertile. Comparing children in the highest PFOS tertile with those in the lowest PFOS tertile showed elevated
but statistically non-significant OR of hyperactivity (OR (95% CI) 1.7 (0.9, 3.2)). In Greenland, elevated PFOS was
associated with higher SDQ-total scores indicating more behavioural problems (β (95% CI) =1.0 (0.1, 2.0)) and
elevated PFOA was associated with higher hyperactivity sub-scale scores indicating more hyperactive behaviour
(β (95% CI) = 0.5 (0.1, 0.9)). Prenatal PFOS and PFOA exposures were not associated with motor difficulties.
Conclusions: Prenatal exposure to PFOS and PFOA may have a small to moderate effect on children’s
neuro-behavioural development, specifically in terms of hyperactive behaviour. The associations were strongest
in Greenland where exposure contrast is largest.
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Perfluorinated alkyl substances (PFAS) are man-made per-
sistent chemicals, which are being widely used due to their
water and oil-repellent properties. Biomonitoring studies
have shown that they are found globally in a variety of liv-
ing organisms, including humans [1-4]. Exposure path-
ways are mainly through diet and drinking water [5,6].
Perfluorooctanoate (PFOA) and perfluorooctane sulfonate
(PFOS) are widespread in the environment in spite of a
phase out since year 2000. They have long serum half-lives
in humans [7] and are known to cross the placenta [8],
which is worrying as fetal and early life is considered to be
the vulnerable period of normal brain development [9].
Some of the most prevalent neuro-developmental disor-
ders are developmental coordination disorder and atten-
tion deficit hyperactivity disorder (ADHD) and they may
be related through common causal pathways [10]. The
world prevalence of developmental coordination disorder
is 5-6% [11-13] and the world prevalence of ADHD is
5-10% [14]. The disorders are related to various predictors
such as fetal alcohol exposure [15] and fetal smoking ex-
posure [16] although newer studies report little evidence
of a causal relation between prenatal smoking exposure
and development of ADHD [17]. Twin studies of ADHD
suggest a high level of heritability, but fetal environmental
pollutant exposures are also likely to play a role [18].
Animal studies suggest associations between prenatal
exposure to PFOS and PFOA and neuro-behavioural defi-
cits [19-21]. Human observational studies on the relation
between PFAS exposures and behaviour are sparse and re-
sults are inconsistent, which may be due to different ex-
posure levels and study designs. One cross-sectional study
reported a positive association between PFOS and PFOA
and ADHD [22], while another study observed an inverse
J-shaped association between PFOA and ADHD across
quartiles of exposure [23], indicating elevated risk of
ADHD among those exposed to medium exposure level
compared to low exposure level. No association was ob-
served between relatively high fetal PFOS and PFOA ex-
posure and behaviour at 7 years of age [24], while another
follow-up study with lower PFAS exposures observed a re-
lation between higher levels of PFOS (but not PFOA) and
worse gross motor function in 2-year old children [25].
The present longitudinal study with a relatively large
number of participants and relatively large exposure
spans investigated the associations between pregnancy
concentrations of PFOS and PFOA at background ex-
posure levels and motor development and behaviour in
5-9-year old children.
Methods
Study population and data collection
During the period from May 2002 to February 2004, 1,441
pregnant women from Greenland, Warsaw (Poland) andKharkiv (Ukraine) were enrolled in the INUENDO (Bio-
persistent organochlorines in diet and human fertility)
birth cohort from antenatal health care clinics and pro-
vided a blood sample at any stage of pregnancy. To be eli-
gible for the study, the woman had to be born in the
country of study, be pregnant and at least 18 years of age.
At baseline, 2,478 women were eligible in Ukraine of
whom 612 (24.7%) participated, and non-participants were
slightly younger than participants but were otherwise
similar. In Greenland, 665 were eligible and 571 (85.9%)
participated, and participants and non-participants were
very similar. In Poland, 690 were eligible and 258 (37.4%)
participated. Unfortunately, we have no information avail-
able for the non-participants from Poland, limiting our
ability to compare participants and non-participants. Fur-
ther details on the baseline study population are available
elsewhere [26]. A follow-up was conducted from January
2010 to May 2012, when the children were between 5 and
9 years old. Parents or guardians responded to questions
concerning lifestyle, motor development, behaviour and
other characteristics in a face-to-face interview or by fill-
ing in a questionnaire themselves.
At follow-up, a total of 1,113 mother-child-pairs
(singleton births) with measured exposure information
participated of the 1,441 pregnant women enrolled at
baseline. After exclusion of mother-child-pairs with
missing information on all 15 DCDQ items (n = 7) the
study population consisted of 1,106 children, distributed
between Greenland (n = 526 (47.6%)), Poland (n = 89
(8.0%)) and Ukraine (n = 491 (44.4%)).
Determination of PFOS and PFOA and cotinine
Plasma concentrations of PFOA, PFOS and cotinine
were analysed, using liquid chromatography-tandem-
mass-spectrometry (LC/MS/MS) at The Department of
Occupational and Environmental Medicine in Lund,
Sweden. A detailed description of the method for PFOS
and PFOA is presented elsewhere [27]. Cotinine was
analysed by the same method. Briefly, aliquots of 100 μl
serum were added 25 μl of a water:acetonitrile (50:50)
solution containing labelled internal standards. Proteins
were precipitated with acetonitrile and vigorously shak-
ing for 30 minutes. The samples were then centrifuged
and the supernatant analyzed using a LC (UFLCXR,
SHIMADZU Corporation, Kyoto, Japan) connected to a
hybrid triple quadrupole linear ion trap mass spectrom-
eter (QTRAP 5500, AB Sciex, Foster City, CA, USA). All
samples were above limits of detection, which were
0.2 ng/ml and 0.04 ng/ml for PFOS and PFOA, respect-
ively. Coefficient of variation of duplicate samples
worked-up and analyzed on different days were 9% for
PFOS and 11% for PFOA. The analyses of PFOA and
PFOS are part of the Round Robin inter-comparison
program (Professor Dr. Med. Hans Drexler, Institute and
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onmental Medicine, University of Erlangen-Nuremberg,
Germany) with results within the tolerance limits.
Assessment of child behaviour and motor abilities and
covariate data
Behaviour was assessed using the parent version of the
standardized questionnaire “The Strength and Difficul-
ties Questionnaire” (SDQ), comprising 25 items on five
scales (emotional, conduct, hyperactivity, peer and pro-
social behaviour) [28]. SDQ is a screening tool used to
identify common mental disorders in children 4 to
16 years of age. The items were coded 0 “not true”, 1
“somewhat true” or 2 “certainly true”. Each scale had a
summed score ranging from 0 to 10. A SDQ-total score
was calculated by summing four of the scales (emotional,
conduct, hyperactivity and peer) with a score range of 0
to 40. Cut-offs on the SDQ were set according to stand-
ard (SDQ-total:0 to 13 = normal, 14 to16 = borderline
and 17 to 40 = abnormal; Emotional symptoms: 0 to
5 = normal, 6 = borderline and 7 to 10 = abnormal; Con-
duct problems: 0 to 3 = normal, 4 = borderline and 5 to
10 = abnormal; Hyperactivity: 0 to 5 = normal, 6 = bor-
derline and 7 to 10 = abnormal; Peer problems: 0 to
3 = normal, 4 to 5 = borderline and 6 to 10 = abnormal;
Pro-social behaviour: 6 to 10 = normal, 5 = borderline
and 1 to 4 = abnormal) [29]. When outcomes were
dichotomised, the cut-offs were normal/borderline ver-
sus abnormal. In all scales, except the pro-social sub-
scale, a high score indicated problems.
Parents were asked to assess their child’s behaviour
during the past six months.
To evaluate the motor development, parents compared
their child’s motor abilities to that of his or her peers
using “Developmental Coordination Disorder Question-
naire 2007” (DCDQ). DCDQ is a screening tool to help
identify motor difficulties in children 5-15-years of age,
comprising 15 items on a 5-point Likert scale with a
total score range of 15 to 75 [30]. A low score indicates
problems. Only continuous DCDQ scores were used in
this study as scores in the three populations were het-
erogeneous and the validity of DCDQ has not been ex-
amined specifically in the countries where the present
study takes place.
Covariate data were collected from the pregnancy and
follow-up questionnaires and included information about
e.g. lifestyle, health and personal characteristics.
Statistical analysis
Missing information
The number of missing values on behaviour, motor de-
velopment and covariates ranged from 0 to 55%. One of
the 15 items (question 12; “your child learns new motor
tasks easily”) was erroneously lacking in the Greenlandicversion of the DCDQ (but not in the Danish version of
the questionnaire used for some participants in
Greenland), which caused 55% missing of the DCDQ in
Greenland, as all items are needed to generate a total
score. In the Greenlandic population, the median of
missing answers of the DCDQ were 2%, and 85% had
answered at least 14 of 15 items of the DCDQ. To in-
crease power and overcome the risk of introducing se-
lection bias by analysing only the complete case dataset,
we used chained multiple imputation, allowing us to
maintain participants with incomplete data [31]. Briefly,
multiple different imputed datasets (m > 1) are created,
and a set of random plausible values replace each miss-
ing value, based on known subject characteristics and
other predictors in the complete dataset. This incorpo-
rates an appropriate variability across the m datasets.
The new m complete datasets are analysed, producing a
single set of results accounting for the variability of the
missing data [31].
We generated 100 imputed datasets in a combined im-
putation that included all three countries. The predictors
were: PFOA, PFOS, the 15 items of the DCDQ, the 5 sub-
scales of the SDQ, maternal cotinine level during preg-
nancy, maternal alcohol consumption before conception,
maternal educational level, maternal age at pregnancy,
birth weight, gestational age at birth, gestational age at
blood sampling, parity, breastfeeding duration, child age at
follow-up and child sex. The robustness of the imputation
model was examined creating fewer (m = 20) and more
(m = 150) datasets and using less and more predictors,
and furthermore, complete case analyses were performed
as sensitivity analyses.
Data analysis
A non-response analysis was performed to check for in-
consistencies between responders (n = 1,113) and non-
responders (n = 328). Spearman’s rank correlation was
used to assess the correlation between maternal preg-
nancy levels of PFOS and PFOA. We used logistic re-
gression models in the primary analyses of PFOS and
PFOA levels and behavioural problems (abnormal SDQ-
total and sub-scale scores) and linear regression in the
investigation of PFOS and PFOA exposure and motor
development. Exposures were a priori decided to be cat-
egorized into tertiles per country as well as pooled, using
the lowest tertile as reference group. Moreover, trends in
exposure-outcome associations were further explored,
using continuous, natural logarithm transformed expo-
sures in linear regression models. To increase power, the
associations between exposures and behavioural out-
comes were also examined using linear regression
models with exposures categorized into tertiles as well
as a continuous variable. All estimates were adjusted for
the most important potential confounders among the
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cluded maternal cotinine level during pregnancy (serum
cotinine ≤10 (non-smoker)/ >10 ng/ ml (smoker)); ma-
ternal alcohol consumption at conception (0, <7, ≥7
drinks per week); maternal age at pregnancy (continu-
ous); child sex and gestational age at blood-sampling
(continuous) [15,16,32,33]. In addition, we explored pos-
sible interactions between the exposures and sex and ex-
posures and country, adding interaction terms to the
model. In a sensitivity analysis of the SDQ, we used the
top 10 percentile cut-off from this sample as a marker of
behavioural problems instead of the standard cut-offs
suggested by Youth in Mind [29] as also used in another
study [24]. Furthermore, duration of breastfeeding was
added as covariate to adjust for postnatal PFAS expo-
sures. Complete case results are presented as supple-
mentary material.
All analyses were performed stratified by population as
well as combined (adjusted for population). Not all ana-
lyses could be performed in the Polish dataset since only
very few cases were present. A p-value less than 0.05
was considered statistically significant. Statistical ana-
lyses were performed using the Stata statistical package
(version 12.1, StataCorp, College Station, Texas, USA).Ethics
The study was approved by local ethical committees;
Polish Bioethical Committee (approval no. 6/2002 of
3.07.2002), Ethical Committee for Human Research in
Greenland (approval no. 2010–13) and the Commission
on Ethics and Bioethics Kharkiv National Medical Uni-
versity in Ukraine (protocol number 7, October 7 2009).
All participating parents signed informed consent.Results
The non-response analysis showed no differences be-
tween responders and non-responders at follow-up con-
cerning exposure levels, maternal educational level,
pregnancy smoking status and maternal age at baseline
(data not shown). The median (10–90 percentile) age of
the children at follow-up was 8 (7 to 9) years in
Greenland compared to 7 (7 to 8) and 8 (7 to 8) years in
Ukraine and Poland, respectively. Personal characteris-
tics of the study population are presented in Table 1.
In comparison with women from Greenland, women
from Poland were older, had lower body mass index
(BMI), more often expected their first child, were non-
smokers and better educated. Women from Ukraine
were younger at recruitment, had lower BMI, were more
often non-smokers and drank less alcohol compared to
women from Greenland (Table 1). The level of missing
data is presented in Table 1, showing highest level of
missing data on the DCDQ in Greenland.The median serum concentrations of PFOS and PFOA
are presented in Table 2 alongside the exposure tertiles
across the three countries and pooled. Median PFOS ex-
posure levels were highest in Greenland (median (10th–90th
percentile) PFOS 20.3 ng/ml (12.0, 37.0)), which is approxi-
mately 4 times higher than the median PFOS exposure level
in Ukraine. The median PFOA levels were highest in
Poland (median (10th-90th percentile) 2.7 ng/ml (1.5, 4.3)).
The Spearman’s correlation coefficient between mater-
nal pregnancy levels of PFOS and PFOA was 0.5 in
Greenland, 0.6 in Poland and 0.5 in Ukraine.
In Table 3, results of the linear regression analyses be-
tween PFOS and PFOA and motor skills (DCDQ) are pre-
sented. In the combined analysis of all three populations,
PFOS and PFOA were associated with a minor decrease in
DCDQ score. All associations between PFOS and PFOA
and motor development were clinically minor and statisti-
cally non-significant. No interaction was observed be-
tween exposures and sex and exposures and country.
The associations between PFOA and PFOS and behav-
ioural problems (continuous SDQ-total and hyperactiv-
ity) are presented in Table 4. In the combined analyses
of all three countries, high PFOA and PFOS exposures
compared with low exposures were associated with a 0.5
point higher hyperactivity scores (more hyperactive be-
haviour). Higher PFOS levels were associated with
higher SDQ-total scores (more behavioural problems) in
Greenland (Table 4). No associations were observed in
Poland and Ukraine. PFOA was positively associated
with hyperactive scores in Greenland (β (95% CI) = 0.5
(0.1, 0.9)) but not in Poland and Ukraine. PFOA was not
associated with SDQ-total in any of the populations.
There was no evidence of interaction between exposures
and sex or between exposures and country.
Table 5 presents results of the adjusted logistic regres-
sion analyses of the associations between PFOS and
PFOA and dichotomized (normal/borderline versus ab-
normal) SDQ-total and hyperactivity. In the combined
analysis, OR (95% CI) for abnormal SDQ-total was 2.7
(1.2, 6.3) comparing highest PFOA tertile to lowest
PFOA tertile. In Greenland, the adjusted OR for hyper-
active behaviour was higher comparing medium and
high PFOA exposures to low PFOA exposure, although
the 95% CIs were wide (OR (95% CI) = 5.4 (1.1, 25.6)
and 6.3 (1.3, 30.1), respectively). In Ukraine, no associa-
tions were observed. PFOS was not associated with ab-
normal SDQ-total in any of the analyses.
Few associations were found for the other SDQ sub-scales
(emotional, conduct, peer and pro-social) (See Additional
file 1). The OR for abnormal pro-social behaviour was also
above 1 in Ukraine but not in Greenland.
Results from complete-case analyses were generally
similar to the imputation-based analyses presented
above (See Additional files 2, 3 and 4).
Table 1 Characteristics of mothers and their children according to country
Characteristics Combined Greenland Ukraine Poland
(N = 1,106) (n = 526) (n = 491) (n = 89)
Outcome
DCDQ-score (points) a 52 (40–69) 63 (51–75) 46 (37–55) 64 (52–73)
Missing, n (%) 298 (27) 289 (55) 6 (1) 3 (3)
SDQ-score (points) a 7 (2–15) 7 (2–14) 8 (4–14) 8 (2–15)
Missing, n (%) 7 (1) 6 (1) 0 (0) 1 (1)
SDQ, n (%)
Normal 954 (86) 455 (88) 424 (86) 75 (85)
Borderline 82 (7) 34 (6) 40 (8) 8 (9)
Abnormal 63 (6) 31 (6) 27 (6) 5 (6)
Hyperactivity, n (%)
Normal 967 (87) 477 (91) 425 (86) 65 (73)
Borderline 70 (6) 20 (4) 42 (9) 8 (9)
Abnormal 62 (6) 23 (4) 24 (5) 15 (17)
Missing, n (%) 7 (1) 6 (1) 0 (0) 1 (1)
Maternal characteristics
Maternal age at pregnancy, years 26 (20–35) 26 (20–37) 24 (20–32) 29 (26–34)
Missing, n (%) 62 (6) 38 (7) 24 (5) 0 (0)
Maternal pre-pregnancy BMI, kg/m2 a 22 (19–28) 24 (20–30) 21 (18–26) 21 (19–24)
Parity, no. (%)
0 650 (59) 167 (33) 399 (81) 84 (94)
1 or more 432 (39) 335 (67) 92 (19) 5 (6)
Missing, n (%) 24 (2) 24 (5) 0 (0) 0 (0)
Maternal cotinine level during pregnancy, no. (%)
>10 ng/ml - smoker 374 (34) 296 (56) 76 (15) 2 (2)
≤10 ng/ml – non-smoker 732 (66) 230 (44) 415 (85) 87 (98)
Maternal alcohol consumption at conception, no. (%)
≤7 drinks/week 1,040 (94) 465 (88) 491 (100) 84 (94)
>7 drinks/week 66 (6) 61 (12) 0 (0) 5 (6)
Missing b 582 (500) 261 (50) 307 (63) 14 (16)
Maternal educational level, left school at age, no. (%)
<18 years 356 (32) 217 (46) 139 (28) 0 (0)
≥18 years 621 (56) 249 (54) 293 (68) 79 (100)
Missing, n (%) 129 (12) 60 (11) 59 (12) 10 (11)
Child characteristics
Sex, no. (%)
Male 595 (54) 282 (53) 260 (53) 53 (60)
Female 505 (45) 241 (46) 228 (46) 36 (40)
Missing, n (%) 6 (1) 3 (1) 3 (1) 0 (0)
Total breastfeeding duration, no. (%)
0 months 62 (6) 17 (4) 43 (9) 2 (2)
<6 months 302 (27) 120 (25) 163 (33) 19 (22)
6–12 months 334 (30) 124 (26) 175 (36) 35 (39)
>12 months 354 (32) 214 (45) 107 (22) 33 (37)
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Table 1 Characteristics of mothers and their children according to country (Continued)
Missing, n (%) 54 (5) 51 (10) 3 (1) 0 (0)
Gestational age, no. (%)
≥37 weeks 1,043 (95) 499 (95) 479 (98) 65 (94)
<37 weeks 37 (3) 24 (5) 9 (2) 4 (6)
Missing, n (%) 26 (2) 3 (1) 3 (1) 20 (22)
Gestational age at blood sample, weeks a 39 (38–41) 25 (13–37) 23 (9–40) 33 (27–37)
Birth weight, grams a 3,430 (2,800-4,130) 3,600 (2,840-4,370) 3,285 (2,800-3,800) 3,460 (2,880-4,000)
Age at follow-up, years a 7 (7–9) 8 (7–9) 7 (7–8) 8 (7–8)
Missing, n (%) 58 (5) 53 (10) 5 (1) 0 (0)
BMI, body mass index; DCDQ, developmental coordination disorder questionnaire; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate; SDQ, strength and
difficulties questionnaire. All percentages are based on complete-case data. a Median (10th-90th percentile). b Missing alcohol information was set to 0 intake.
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offs results were somewhat attenuated but the overall
pattern did not change (Additional file 5). Adding dur-
ation of breastfeeding as a covariate to the models did
not change direction or significance of results.
Results of sensitivity analyses of smaller and larger im-
putation models showed similar results, indicating a ro-
bust imputation model.
Discussion
We observed a small to moderate positive association
between pregnancy levels of PFOA and child hyperactive
behaviour in the total sample, which was mainly attrib-
utable to associations in Greenland. In Greenland, PFOS
was associated with behavioural problems (SDQ-total)
(not in Poland and Ukraine), whereas PFOA was associ-
ated with hyperactivity. Only minor associations ap-
peared in relation to other SDQ sub-scales and none to
motor development, as measured using DCDQ.
The mechanism related to the association between pre-
natal PFAS exposure and behavioural and motor problem
is unclear. However, an association between prenatal
PFOS exposure and thyroid hormone disruption has been
reported in mice [34]. In humans, higher pregnancy levelsTable 2 Range (ng/ml) of PFOS/PFOA plasma concentrations,
Exposure Tertile Combine
(N = 1,10
Pregnancy PFOS Median (10th-90th percentile) 10.0 (3.6,
Low tertile 0.7-6.2
Medium tertile 6.2-16.6
High tertile 16.6-87.3
Pregnancy PFOA Median (10th-90th percentile) 1.4 (0.7, 3
Low tertile 0.2-1.1
Medium tertile 1.1-1.9
High tertile 1.9-9.8
PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate.of PFOS have been associated with higher pregnancy
levels of thyroid-stimulating hormone (TSH) [35], and
higher pregnancy levels of some PFAS (perfluorononanoic
acid (PFNA), perfluoroundecanoic acid (PFUnDA) and
perfluorododecanoic acid (PFDoDA) have been associated
with lower infant cord levels of triiodothyronine (T3) and
total free thyroxine (T4) [36]. Since thyroid hormones are
essential for fetal and early life neurologic development, a
disruption by prenatal PFAS exposures could possibly im-
pair healthy neurodevelopment.
The results of epidemiological studies examining the
neurodevelopmental effects of PFAS are few and incon-
clusive. Fei et al. reported no associations between high
pregnancy levels of PFOA (median (inter-quartile-range):
5.4 (4.0-7.1 ng/ml)) and PFOS (34.4 (26.6-44.5 ng/ml))
and developmental coordination disorder (assessed by
DCDQ’07) at 7 years among a sub-sample of 537 partici-
pants from the Danish National Birth Cohort [24], which
is in accordance with our results. In the same study, no
associations were observed between PFOS and PFOA
and SDQ-total or any of the SDQ sub-scales, using top
10 percentile cut-offs [24]. This is in accordance with
our sensitivity analysis using top 10 percentile cut-off,
whereas we observed associations between PFOA andby tertile, in pregnant women
d Greenland Ukraine Poland
6) (n = 526) (n = 491) (n = 89)
27,4) 20.3 (12.0-37.0) 5.0 (2.9-8.2) 8.0 (5.3-12.7)
4.1-16.8 0.7-4.2 2.5-7.0
16.8-23.9 4.2-5.9 7.1-9.6
23.9-87.3 5.9-18.1 9.7-21.3
.0) 1.8 (1.0-3.1) 1.0 (0.5-1.7) 2.7 (1.5-4.3)
0.5-1.5 0.2-0.8 1.0-2.2
1.5-2.2 0.8-1.1 2.2-3.1
2.2-5.1 1.1-9.8 3.1-9.8
Table 3 Associationsa between pregnancy levels of PFOS/PFOA (ng/ml) and offspring DCDQ-scoreb
Exposure Combinedd (N = 1,106) Greenland (n = 526) Ukraine (n = 491) Poland (n = 89)
β (95% CI) β (95% CI) β (95% CI) β (95% CI)
PFOS Low ref ref ref ref
Medium −0.4 (−1.9, 1.2) −1.2 (−3.0, 0.7) 1.4 (−0.2, 3.1) −0.3 (−6.0, 5.3)
High −1.7 (−3.8, 0.5) −0.7 (−2.6, 1.2) 0.6 (−1.1, 2.2) −2.1 (−7.8, 3.5)
Continuousc −0.1 (−1.2, 1.1) −0.2 (−1.9, 1.4) 0.5 (−1.0, 2.0) −2.4 (−9.1, 4.3)
PFOA Low ref ref ref ref
Medium −0.6 (−1.9, 0.7) −1.2 (−3.0, 0.7) −0.2 (−1.8, 1.4) 1.5 (−4.1, 7.1)
High −0.4 (−1.9, 1.1) −0.1 (−2.0, 1.7) −1.2 (−2.8, 0.5) −3.7 (−9.3, 1.9)
Continuousc −0.2 (−1.2, 0.9) 0.8 (−0.8, 2.5) −0.6 (−1.9, 0.8) −2.7 (−8.3, 2.8)
CI, confidence interval; DCDQ, developmental coordination disorder questionnaire; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate; Ref, referece group.
aAdjusted for: maternal cotinine level during pregnancy, maternal alcohol consumption at conception, maternal age at pregnancy, gestational age at blood-sampling
and child sex. bDCDQ score range from 15 to 75 (low scores indicate motor problems). cβ = the change in score according to one natural-log unit increase in PFOA and
PFOS. dadditionally adjusted for country.
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http://www.ehjournal.net/content/14/1/2hyperactivity in Greenland and in the combined analysis
of the three countries in our main analysis using stand-
ard cut-offs. Furthermore, we observed a minor positive
association between PFOS and SDQ-total in the com-
bined analysis, however, statistically non-significant,
whereas the country specific results were more heteroge-
neous. In the present study, we used the standard cut-
offs suggested by Youth in Mind [29] and 804 of the
1,106 included children were older than 7 years, which
may explain the difference in our results.Table 4 Associationsa between pregnancy levels of PFOS/PFO
Combined (N = 1,106)e
Scale (score range) Difference 95% CI
SDQ (0–40)b PFOA Low Ref -
Medium 0.3 −0.5, 1.0
High 0.7 −0.2, 1.5
Continuousd 0.1 −0.5, 0.7
Hyperactivity (0–10)c Low Ref -
Medium 0.1 −0.3, 0.4
High 0.5 0.1, 0.9
Continuousd 0.3 0.0, 0.5
SDQ (0–40)b PFOS Low Ref -
Medium 0.1 −1.0, 0.8
High 1.1 −0.1, 2.3
Continuousd 0.3 −0.3, 1.0
Hyperactivity (0–10)c Low Ref -
Medium 0.1 −0.3-0.5
High 0.5 0.0, 1.0
Continuousd 0.2 −0.1, 0.5
CI, confidence interval; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate;
aAdjusted for: maternal cotinine level during pregnancy, maternal alcohol consumption
and child sex. bHigh scores indicate behavioural problems. cHigh scores indicate more
increase in PFOA and PFOS. eAdditionally adjusted for country.A small Taiwanese birth cohort study with exposure
levels equivalent to exposure levels in this study observed
associations between prenatal PFOS and gross motor
functions at 2 years of age, whereas no association was re-
ported between PFOA and any neuro-behavioural out-
come [25]. Direct comparison with this study is, however,
hampered since their outcome measure was assessed by
use of a questionnaire developed specifically for Chinese
populations. Some inconsistencies were present in our re-
sults of prenatal PFAS exposure and motor development,A (ng/ml) and offspring SDQ-total and hyperactivity score
Greenland (n = 526) Ukraine (n = 491) Poland (n = 89)
Difference 95% CI Difference 95% CI Difference 95% CI
Ref - Ref - Ref -
0.7 −0.4, 1.7 −0.9 −1.9, 0.1 0.8 −1.9, 3.4
0.5 −0.6, 1.5 −0.3 −1.3, 0.7 1.8 −0.8, 4.5
0.3 −0.6, 1.3 −0.5 −1.3, 0.4 2.1 −0.4, 4.7
Ref - Ref - Ref -
0.5 0.0, 1.0 −0.3 −0.7, 0.1 1.1 −0.4, 2.6
0.6 0.1, 1.1 −0.2 −0.6, 0.2 0.9 −0.6, 2.4
0.5 0.1, 0.9 −0.1 −0.5, 0.2 1.2 −0.3, 2.6
Ref - Ref - Ref -
1.3 0.3, 2.4 −1.0 −2.0, 0.0 −0.1 −2.7, 2.5
1.1 0.1, 2.2 −1.0 −2.2-0.0 2.0 −0.6, 4.6
1.0 0.1, 2.0 −1.0 −1.6, 0.2 2.6 −0.5, 5.7
Ref - Ref - Ref -
0.4 −0.1, 0.8 −0.2 −0.6, 0.2 0.9 −0.5, 2.4
0.3 −0.2, 0.7 −0.1 −0.5, 0.3 1.3 −0.1, 2.8
0.3 −0.1, 0.7 −0.1 −0.4, 0.3 1.5 −0.3, 3.2
Ref, reference group; SDQ, strength and difficulties questionnaire.
at conception, maternal age at pregnancy, gestational age at blood-sampling
hyperactive behaviour. dβ = the change in score according to one natural-log unit
Table 5 Associationsa between pregnancy levels of PFOS/PFOA (ng/ml) and offspring behavioural and hyperactivity
problems
Scale Combinede Greenland Ukraine Poland
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
(N = 1,106) (n = 526) (n = 491) (n = 89)
SDQ-totalb
PFOS
Low 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
Medium 1.1 (0.5, 2.5) 1.7 (0.7, 4.0) 0.6 (0.2, 1.6) -
High 1.5 (0.5, 4.8) 0.8 (0.3, 2.2) 0.6 (0.2, 1.5) -
Continuousd 1.1 (0.6, 2.0) 0.9 (0.4, 2.1) 1.0 (0.4, 2.5) -
PFOA
Low 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
Medium 2.0 (1.0, 4.2) 2.7 (1.0, 7.5) 1.3 (0.5, 3.5) -
High 2.7 (1.2, 6.3) 1.9 (0.7, 5.4) 1.5 (0.6, 4.2) -
Continuousd 1.5 (0.9, 2.6) 2.1 (0.8, 5.2) 1.0 (0.4, 2.3) -
Hyperactivityc
PFOS
Low 1.0 (ref) 1.0 (ref) 1.0 (ref) -
Medium 1.2 (0.5, 2.5) 1.1 (0.4, 3.4) 1.2 (0.4, 3.3) -
High 1.4 (0.4, 4.9) 1.3 (0.4, 3.9) 1.4 (0.5, 3.9) -
Continuousd 1.7 (0.9, 3.2) 1.9 (0.7, 4.8) 1.3 (0.5, 3.4) -
PFOA
Low 1.0 (ref) 1.0 (ref) 1.0 (ref) -
Medium 0.8 (0.4, 2.0) 5.4 (1.1, 25.6) 0.8 (0.3, 2.3) -
High 3.1 (1.3, 7.2) 6.3 (1.3, 30.1) 0.9 (0.3, 2.4) -
Continuousd 1.6 (0.9, 2.8) 3.6 (1.2, 3.7) 0.8 (0.3, 1.9) -
CI, confidence interval; OR, odds ratio; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate; SDQ, strength and difficulties questionnaire; Ref,
reference group.
aAdjusted for maternal cotinine level during pregnancy, maternal alcohol consumption at conception, child sex, maternal age at pregnancy and gestational age at
blood sampling.
bSDQ cut-offs: normal and borderline (0 to 16) versus abnormal (17 to 40).
cHyperactivity cut-offs: normal and borderline (0 to 6) versus (7 to 10).
dThe change in OR according to one natural logarithm increase in exposures.
eAdditionally adjusted for country.
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http://www.ehjournal.net/content/14/1/2and we did not observe any consistent and clinically rele-
vant associations which could be due to older age at
follow-up or lack of sensitivity of the DCDQ, as the ori-
ginal version of the questionnaire has high sensitivity in
populations with high prevalence of motor difficulties and
lower sensitivity in a background population [37].
The C8 Health Project (which reports health outcomes
in relation to PFOA contamination of drinking water
from the Dupont factory in the United States) reported
only minor associations between high levels of childhood
PFOA measured at 2–8 years of age and a range of
neuropsychological outcomes assessed at 6–12 years
among a sub-sample of 321 children [38,39], however,
an interaction between PFOA and sex was reported in
the analysis of ADHD-like behaviour, indicating high
PFOA exposure to be protective among boys andadverse among girls [38]. When in utero PFOA expo-
sures were estimated in a pharmacokinetic model, higher
PFOA levels were associated with fewer signs of ADHD
(using the clinical confidence index of Conners’ continu-
ous performance test- II) [39]. In the study by Stein
et al. [38], the exposures were measured postnatally, and
in the study by Stein et al., [39], the prenatal exposures
were estimated in a toxicokinetic model, whereas we
measured the prenatal exposures in maternal blood. Fur-
thermore, different study designs and exposure and out-
comes assessments were used in these studies and also,
the offspring had different ages at examination, which
may explain their findings as we saw no signs of inter-
action between PFOA and sex.
We acknowledge that this study has some limitations.
In the analysis of categorical exposures stratified by
Høyer et al. Environmental Health 2015, 14:2 Page 9 of 11
http://www.ehjournal.net/content/14/1/2country, we used country specific tertiles as exposure
levels differed considerably between countries. This
could in part explain the inconsistencies in our findings.
Furthermore, PFAS levels and SDQ and DCDQ results
did vary in the three countries included in this study
which further may account for the inconsistent findings
between countries.
There is a risk of exposure misclassification since
blood samples were collected throughout pregnancy in
our study and PFAS tend to decrease during pregnancy
[40]. However, we addressed this issue by adjusting for
gestational age at blood sampling, although we recognize
that this may not have completely eliminated the risk of
information bias.
The DCDQ is developed as a screening tool and
should not be used for diagnostics [41]. The question-
naire has not been validated in the three countries repre-
sented in this study, and thus there is a risk of
misclassification of motor problems. However, we be-
lieve the questionnaire is suitable for detecting a differ-
ence in motor abilities according to PFOS and PFOA
exposure levels within the three countries, and since we
did not use the cut-offs for indication of motor difficul-
ties, this should not be a large concern.
We chose to use the standard cut-offs for behavioral
problems as no country specific cut-offs exist for
Greenland, Ukraine and Poland. This enabled us to com-
pare results between countries but may have resulted in
misclassification of the SDQ outcome. SDQ as a screen-
ing tool has a high validity as well as reliability [42,43],
and our sensitivity analysis, using top ten percentile cut-
offs in general suggested consistent results.
Missing data can cause selection bias and to overcome
this challenge, we performed several multiple imputation
analyses, and results were consistent. A lack of demo-
graphic information concerning the Polish non-participants
at baseline limited our ability to compare participants and
non-participants and selection bias in the Polish results can
not be ruled out. Furthermore, the relatively low participa-
tion rate of 34% at follow-up in Poland poses a risk of selec-
tion bias. However, the non-response analysis at follow-up
showed no evidence of difference between responders and
non-responders, indicating low risk of selection bias by loss
to follow-up.
It is difficult to estimate to what extent postnatal PFAS
exposure may have influenced the results. In a sensitivity
analysis, we adjusted for duration of breastfeeding,
which did not materially change the results. However,
residual confounding by postnatal PFAS exposure can
not be completely ruled out.
We measured PFAS levels at all periods during preg-
nancy as a measure of fetal exposure. However, it is not
clear to what extent this reflects the vulnerable window of
exposure. Others have reported high correlation between1st and 2nd trimester PFOA levels and because PFOA and
PFOS have long half-lives, we believe blood-sampling
throughout pregnancy is of minor concern.
The Polish results should be interpreted with caution,
since the Polish sample is small. However, samples from
Greenland and Ukraine and the pooled analysis are of
considerable size and, thus, results should be robust.Conclusions
Prenatal exposure to PFOS and PFOA may have a small
to moderate effect on children’s neuro-behavioural de-
velopment at the age of 5–9 years, specifically in terms
of hyperactive behaviour. The associations were largest
in Greenland, where the exposure contrast is largest. No
association was observed in relation to motor skills.
Standardized measures of behavioural- and motor prob-
lems were used and results were consistent across nu-
merous sensitivity analyses.Additional files
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